{"id":110322,"name":"CAREDX, INC.","slug":"caredx-inc","state":"CA","description":"Molecular diagnostics","totalSpending":1330000,"filings":18,"yearlySpending":[{"year":2019,"income":160000},{"year":2020,"income":240000},{"year":2021,"income":20000},{"year":2022,"income":400000},{"year":2024,"income":360000},{"year":2025,"income":150000}],"firms":["BROWNSTEIN HYATT FARBER SCHRECK, LLP"],"lobbyists":["R. NICHOLSON","PETER GOODLOE","CHARLYN IOVINO","NADEAM ELSHAMI","EMILY FELDER","LAURA BOLLIER","ELIZABETH MAIER","ADAM STEINMETZ","JONATHAN TOWERS","TRAVIS NORTON"],"issues":["HCR","MMM","MED"],"sampleDescriptions":["CMS reimbursement","Medicare reimbursement","Immunosuppressant legislation","Medicare reimbursement issues","Immuno suppressant legislation","Immunosuppressant Legislation; education regarding CareDxs suite of Immunosuppressant products and services","Use of bioscience markers with regard to organ transplant rejection"],"years":[2019,2020,2021,2022,2024,2025]}